Abstract
INTRODUCTION: The use of systemic corticosteroids for upper respiratory tract infections has become increasingly common, but remains controversial. Given their purported ability to decrease duration of illness and hasten recovery, systemic corticosteroids offer an attractive treatment modality for flight surgeons desiring to minimize DNIF (Duty Not Including Flying) time. This commentary presents an evidence-based approach to the use of systemic corticosteroids for upper respiratory tract infections in flyers, concluding that the current body of evidence and missional concerns justify their routine use in sore throat and acute rhinosinusitis.Tanael M. Systemic corticosteroids for upper respiratory tract infections in the flyer. Aerosp Med Hum Perform. 2020; 91(5):453-454.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
